Clinical diagnostics role of serum Chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndrome

The study was aimed at identifying clinical diagnostics role of Chlamydia pneumoniae antibodies (ATCP), IgA, G, M, and acute phase proteins in acute coronary syndrome (ACS). In 91 hospitalized ACS patients, aged 35-70 years (mean age 54, 74+0, 89 years), serum levels of specific ATCP IgM, IgA, IgG,...

Full description

Saved in:
Bibliographic Details
Main Authors: A. M. Pishchukhina, A. V. Dedov, T. N. Panova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2007-08-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2182
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839577110814916608
author A. M. Pishchukhina
A. V. Dedov
T. N. Panova
author_facet A. M. Pishchukhina
A. V. Dedov
T. N. Panova
author_sort A. M. Pishchukhina
collection DOAJ
description The study was aimed at identifying clinical diagnostics role of Chlamydia pneumoniae antibodies (ATCP), IgA, G, M, and acute phase proteins in acute coronary syndrome (ACS). In 91 hospitalized ACS patients, aged 35-70 years (mean age 54, 74+0, 89 years), serum levels of specific ATCP IgM, IgA, IgG, C-reactive protein (CRP), and fibrinogen (F) were measured at Days 1, 14, and 27. The participants were divided into two groups: with or without ST segment elevation (ACS ST 1 and ACS STO, respectively). Specific ATCP titers were measured by immuno-enzyme method (test systems SeroCP™IgG, IgA, IgM EIISA, Savyon, Israel). In ACS ST 1 group, ATCP IgM titers, CRP (5, 6 mg/l) and F (4, 7 mg/l) levels were increased, ACS clinical course was more severe, with myocardial infarction (MI) development in 100 % patients; complications were more common. In ACS STO group, no signs of active CP infection were observed; CRP (2, 5 mg/l) and F (3, 7 g/l) level increase was less prominent; MI developed in 50 %. ATCP, CRP, and F level measurement in ACS facilitated differential diagnostics, as well as complication and outcome prognosis.
format Article
id doaj-art-fe6d363721c44f59bb6a0dec77fe9ac8
institution Matheson Library
issn 1560-4071
2618-7620
language Russian
publishDate 2007-08-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-fe6d363721c44f59bb6a0dec77fe9ac82025-08-04T13:00:01Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202007-08-010433351934Clinical diagnostics role of serum Chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndromeA. M. Pishchukhina0A. V. Dedov1T. N. Panova2Астраханская государственная медицинская академияАстраханская государственная медицинская академияАстраханская государственная медицинская академияThe study was aimed at identifying clinical diagnostics role of Chlamydia pneumoniae antibodies (ATCP), IgA, G, M, and acute phase proteins in acute coronary syndrome (ACS). In 91 hospitalized ACS patients, aged 35-70 years (mean age 54, 74+0, 89 years), serum levels of specific ATCP IgM, IgA, IgG, C-reactive protein (CRP), and fibrinogen (F) were measured at Days 1, 14, and 27. The participants were divided into two groups: with or without ST segment elevation (ACS ST 1 and ACS STO, respectively). Specific ATCP titers were measured by immuno-enzyme method (test systems SeroCP™IgG, IgA, IgM EIISA, Savyon, Israel). In ACS ST 1 group, ATCP IgM titers, CRP (5, 6 mg/l) and F (4, 7 mg/l) levels were increased, ACS clinical course was more severe, with myocardial infarction (MI) development in 100 % patients; complications were more common. In ACS STO group, no signs of active CP infection were observed; CRP (2, 5 mg/l) and F (3, 7 g/l) level increase was less prominent; MI developed in 50 %. ATCP, CRP, and F level measurement in ACS facilitated differential diagnostics, as well as complication and outcome prognosis.https://russjcardiol.elpub.ru/jour/article/view/2182acute coronary syndromeatherosclerosiscoronary heart diseasechlamydia pneumoniae antibodiescfreactive proteinfibrinogen
spellingShingle A. M. Pishchukhina
A. V. Dedov
T. N. Panova
Clinical diagnostics role of serum Chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndrome
Российский кардиологический журнал
acute coronary syndrome
atherosclerosis
coronary heart disease
chlamydia pneumoniae antibodies
cfreactive protein
fibrinogen
title Clinical diagnostics role of serum Chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndrome
title_full Clinical diagnostics role of serum Chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndrome
title_fullStr Clinical diagnostics role of serum Chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndrome
title_full_unstemmed Clinical diagnostics role of serum Chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndrome
title_short Clinical diagnostics role of serum Chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndrome
title_sort clinical diagnostics role of serum chlamydia pneumoniae antibodies and acute phase proteins in acute coronary syndrome
topic acute coronary syndrome
atherosclerosis
coronary heart disease
chlamydia pneumoniae antibodies
cfreactive protein
fibrinogen
url https://russjcardiol.elpub.ru/jour/article/view/2182
work_keys_str_mv AT ampishchukhina clinicaldiagnosticsroleofserumchlamydiapneumoniaeantibodiesandacutephaseproteinsinacutecoronarysyndrome
AT avdedov clinicaldiagnosticsroleofserumchlamydiapneumoniaeantibodiesandacutephaseproteinsinacutecoronarysyndrome
AT tnpanova clinicaldiagnosticsroleofserumchlamydiapneumoniaeantibodiesandacutephaseproteinsinacutecoronarysyndrome